{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:22:25Z","timestamp":1788121345058,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neuropharm.2023.109673","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:59:59Z","timestamp":1690592399000},"page":"109673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Tetrandrine attenuates SNI-induced mechanical allodynia by inhibiting spinal CKLF1"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-5902","authenticated-orcid":false,"given":"Zhi-Ling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo-Di","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuropharm.2023.109673_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/13813455.2019.1700048","article-title":"Involvement of pro-inflammatory cytokines in diabetic neuropathic pain via central PI3K\/Akt\/mTOR signal pathway","volume":"127","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109673_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2023.109673_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106577","article-title":"CKLF1\/CCR5 axis is involved in neutrophils migration of rats with transient cerebral ischemia","volume":"85","author":"Chen","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2023.109673_bib4","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neuropharm.2023.109673_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2023.109673_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pain.2007.05.002","article-title":"Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain","volume":"135","author":"Echeverry","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109673_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2023.109673_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2012.10.015","article-title":"Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor","volume":"238","author":"Gao","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109673_bib9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/jor.23155","article-title":"Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-kappaB inactivation","volume":"34","author":"Gao","year":"2016","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.neuropharm.2023.109673_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-pharmtox-051421-112259","article-title":"Neuropathic pain: mechanisms, sex differences, and potential therapies for a global problem","volume":"63","author":"Ghazisaeidi","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2023.109673_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2011.01.103","article-title":"Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-kappaB activation in a rat model of Alzheimer's disease induced by amyloid-beta(1-42)","volume":"1384","author":"He","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109673_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-11-112","article-title":"Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats","volume":"11","author":"Kong","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109673_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.intimp.2014.02.014","article-title":"The chemokine-like factor 1 induces asthmatic pathological change by activating nuclear factor-kappaB signaling pathway","volume":"20","author":"Li","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2023.109673_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155429","article-title":"Inhibition of CKLF1 ameliorates hepatic ischemia-reperfusion injury via MAPK pathway","volume":"141","author":"Li","year":"2021","journal-title":"Cytokine"},{"issue":"13","key":"10.1016\/j.neuropharm.2023.109673_bib15","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-18-3510","article-title":"CKLF1 enhances inflammation-mediated carcinogenesis and prevents doxorubicin-induced apoptosis via IL6\/STAT3 signaling in HCC","volume":"25","author":"Liu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2023.109673_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105957","article-title":"Role of neuroglia in neuropathic pain and depression","volume":"174","author":"Liu","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109673_bib17","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s11064-022-03553-9","article-title":"Tetrandrine ameliorates traumatic brain injury by regulating autophagy to reduce ferroptosis","volume":"47","author":"Liu","year":"2022","journal-title":"Neurochem. Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109673_bib18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/cns.13694","article-title":"Spinal microglial beta-endorphin signaling mediates IL-10 and exenatide-induced inhibition of synaptic plasticity in neuropathic pain","volume":"27","author":"Ma","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2023.109673_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109673_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neures.2017.10.004","article-title":"Astrocyte reactivity and astrogliosis after spinal cord injury","volume":"126","author":"Okada","year":"2018","journal-title":"Neurosci. Res."},{"issue":"4\u20135","key":"10.1016\/j.neuropharm.2023.109673_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lfs.2012.12.009","article-title":"Combined antiallodynic effect of Neurotropin(R) and pregabalin in rats with L5-spinal nerve ligation","volume":"92","author":"Okazaki","year":"2013","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109673_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023600","article-title":"Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials","volume":"9","author":"Onakpoya","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109673_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.17116\/jnevro20221220617","article-title":"[Neuroinflammation in the pathogenesis of central neuropathic pain]","volume":"122","author":"Ospelnikova","year":"2022","journal-title":"Zh. Nevrol. Psikhiatr. Im. S S Korsakova"},{"issue":"21","key":"10.1016\/j.neuropharm.2023.109673_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/polym13213837","article-title":"Preclinical evaluation of polymeric nanocomposite containing pregabalin for sustained release as potential therapy for neuropathic pain","volume":"13","author":"Rodrigues","year":"2021","journal-title":"Polymers"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109673_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","article-title":"NF-kappaB-Mediated neuroinflammation in Parkinson's disease and potential therapeutic effect of polyphenols","volume":"37","author":"Singh","year":"2020","journal-title":"Neurotox. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109673_bib26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109673_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8685954","article-title":"Therapeutic approaches for peripheral and central neuropathic pain","author":"Szok","year":"2019","journal-title":"Behav Neurol 2019"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109673_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12929-022-00871-6","article-title":"Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies","volume":"29","author":"Tong","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109673_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2012.05.019","article-title":"Developmental expression of chemokine-like factor 1, a novel member of chemokines family, in postnatal rat cerebral cortex","volume":"519","author":"Wang","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109673_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2020.11.030","article-title":"Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice","volume":"92","author":"Yi","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2023.109673_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107869","article-title":"Wnt1\/beta-catenin signaling upregulates spinal VGLUT2 expression to control neuropathic pain in mice","volume":"164","author":"Zhang","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109673_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094586","article-title":"Antinociceptive effect of tetrandrine on LPS-induced hyperalgesia via the inhibition of IKKbeta phosphorylation and the COX-2\/PGE(2) pathway in mice","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109673_bib33","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41401-021-00746-w","article-title":"Neuronal chemokine-like-factor 1 (CKLF1) up-regulation promotes M1 polarization of microglia in rat brain after stroke","volume":"43","author":"Zhou","year":"2022","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:37:20Z","timestamp":1722008240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"alternative-id":["S0028390823002630"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109673","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrandrine attenuates SNI-induced mechanical allodynia by inhibiting spinal CKLF1","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109673"}}